Results 171 to 180 of about 42,500 (221)

Current view on the etiopathogenesis of aplastic anemia. [PDF]

open access: yesKorean J Physiol Pharmacol
Ucar MA, Sener M, Dokuyucu R.
europepmc   +1 more source

Aplastic anemia: Pathophysiology

Seminars in Hematology, 2022
Bone marrow failure (BMF) syndromes are a heterogeneous group of benign hematological conditions characterized by uni- or multi-lineage marrow and/or peripheral blood cytopenia(s), and can be classified in constitutional or acquired syndromes based on pathophysiology.
Giudice V., Selleri C.
openaire   +3 more sources

Factitial Aplastic Anemia

The Journal of Nervous and Mental Disease, 1984
A 29-year-old married nurse with pancytopenia was discovered to be surreptitiously ingesting alkylating agents. Despite her life-threatening behavior, there was no evidence that she was psychotic, depressed, or cognitively impaired. Psychological testing was indicative of a sociopathic personality.
C V, Ford   +3 more
openaire   +2 more sources

The Aplastic Anemias

Hospital Practice, 1980
Bone marrow transplantation and androgen therapy offer some hope of survival for patients with aplastic anemia, whether the disease is idiopathic or induced by drugs or toxins.
openaire   +2 more sources

Fatal Aplastic Anemia

JAMA: The Journal of the American Medical Association, 1982
To the Editor.— Two cases of fatal aplastic anemia following the use of topical ocular chloramphenicol have been recently reported. 1,2 Regardless of dosage, systemic chloramphenicol can cause an idiosyncratic, usually fatal, hemopoietic event, with an incidence rate of one in 30,000 to 50,000 patients. This incidence is 13 times greater than the risk
openaire   +2 more sources

Home - About - Disclaimer - Privacy